Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000270214 | SCV000399339 | likely benign | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000427460 | SCV000510613 | likely benign | not provided | 2017-01-02 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Gene |
RCV000427460 | SCV000524273 | benign | not provided | 2018-08-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000427460 | SCV002407342 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000270214 | SCV002514280 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002328837 | SCV002631597 | likely benign | Cardiovascular phenotype | 2019-03-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |